Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women

Oncotarget

Volumn 7, Issue 27, 2016, Pages 41047-41052

  Wu, Haijing ^a   Shang, Xiaofei ^a   Shi, Yu ^a   Yang, Zhirong ^a   Zhao, Jun ^a   Yang, Min ^a   Li, Yan ^b   Xu, Shiqiang ^a  

^a SICHUAN CANCER HOSPITAL   (China)

^b NANCHANG UNIVERSITY   (China)

Author keywords

Genetic variants; HOTAIR; Long noncoding RNA; Ovarian cancer

Indexed keywords

HOTAIR LONG UNTRANSLATED RNA, HUMAN; LONG UNTRANSLATED RNA;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; GENOTYPE; HUMAN; MIDDLE AGED; NEOPLASM; OVARY TUMOR; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; RNA, LONG NONCODING;

EID: 84997465433     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8535     Document Type: Article

References (23)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65:5-29.
2. Nagaraj AB, Joseph P, Kovalenko O, Singh S, Armstrong A, Redline R, Resnick K, Zanotti K, Waggoner S, DiFeo A. Critical role of wnt/beta-catenin signaling in driving epithelial ovarian cancer platinum resistance. Oncotarget. 2015; 6:23720-23734. doi: 10.18632/ oncotarget.4690.
3. Auer K, Bachmayr-Heyda A, Aust S, Sukhbaatar N, Reiner AT, Grimm C, Horvat R, Zeillinger R, Pils D. Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome. Oncotarget. 2015; 6:17261-17275. doi: 10.18632/oncotarget.3746.
4. Haruta S, Furukawa N, Yoshizawa Y, Tsunemi T, Nagai A, Kawaguchi R, Tanase Y, Yoshida S, Kobayashi H. Molecular genetics and epidemiology of epithelial ovarian cancer (review). Oncol Rep. 2011; 26:1347-1356.
5. Zhou C, Ye L, Jiang C, Bai J, Chi Y, Zhang H. Long noncoding rna hotair, a hypoxia-inducible factor-1alpha activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer. Tumour Biol. 2015; 36:9179-88.
6. Jing L, Yuan W, Ruofan D, Jinjin Y, Haifeng Q. Hotair enhanced aggressive biological behaviors and induced radio-resistance via inhibiting p21 in cervical cancer. Tumour Biol. 2015; 36:3611-3619.
7. Xue Y, Gu D, Ma G, Zhu L, Hua Q, Chu H, Tong N, Chen J, Zhang Z, Wang M. Genetic variants in lncrna hotair are associated with risk of colorectal cancer. Mutagenesis 2015; 30:303-310.
8. Yan TH, Lu SW, Huang YQ, Que GB, Chen JH, Chen YP, Zhang HB, Liang XL, Jiang JH. Upregulation of the long noncoding rna hotair predicts recurrence in stage ta/t1 bladder cancer. Tumour Biol. 2014; 35:10249-10257.
9. Huang L, Liao LM, Liu AW, Wu JB, Cheng XL, Lin JX, Zheng M. Overexpression of long noncoding rna hotair predicts a poor prognosis in patients with cervical cancer. Arch Gynecol Obstet. 2014; 290:717-723.
10. Lu L, Zhu G, Zhang C, Deng Q, Katsaros D, Mayne ST, Risch HA, Mu L, Canuto EM, Gregori G, Benedetto C, Yu H. Association of large noncoding rna hotair expression and its downstream intergenic cpg island methylation with survival in breast cancer. Breast Cancer Res Treat. 2012; 136:875-883.
11. Kim K, Jutooru I, Chadalapaka G, Johnson G, Frank J, Burghardt R, Kim S, Safe S. Hotair is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer. Oncogene. 2013; 32:1616-1625.
12. Gupta RA, Shah N, Wang KC, Kim J, Horlings HM, Wong DJ, Tsai MC, Hung T, Argani P, Rinn JL, Wang Y, Brzoska P, Kong B, et al. Long non-coding rna hotair reprograms chromatin state to promote cancer metastasis. Nature. 2010; 464:1071-1076.
13. Wan Y, Chang HY: Hotair. Flight of noncoding rnas in cancer metastasis. Cell Cycle. 2010; 9:3391-3392.
14. Niinuma T, Suzuki H, Nojima M, Nosho K, Yamamoto H, Takamaru H, Yamamoto E, Maruyama R, Nobuoka T, Miyazaki Y, Nishida T, Bamba T, Kanda T, et al. Upregulation of mir-196a and hotair drive malignant character in gastrointestinal stromal tumors. Cancer Res 2012; 72:1126-1136.
15. Cai B, Song XQ, Cai JP, Zhang S. Hotair: A cancer-related long non-coding rna. Neoplasma. 2014; 61:379-391.
16. Loewen G, Jayawickramarajah J, Zhuo Y, Shan B. Functions of lncrna hotair in lung cancer. J Hematol Oncol. 2014; 7:90.
17. Loewen G, Zhuo Y, Zhuang Y, Jayawickramarajah J, Shan B. Lincrna hotair as a novel promoter of cancer progression. J Cancer Res Updat. 2014; 3:134-140.
18. Wu Y, Zhang L, Wang Y, Li H, Ren X, Wei F, Yu W, Wang X, Yu J, Hao X. Long noncoding rna hotair involvement in cancer. Tumour Biol. 2014; 35:9531-9538.
19. Zhuang Y, Nguyen HT, Burow ME, Zhuo Y, El-Dahr SS, Yao X, Cao S, Flemington EK, Nephew KP, Fang F, Collins- Burow B, Rhodes LV, Yu Q, et al. Elevated expression of long intergenic non-coding rna hotair in a basal-like variant of mcf-7 breast cancer cells. Mol Carcinog. 2015; 54:1656-67.
20. Du M, Wang W, Jin H, Wang Q, Ge Y, Lu J, Ma G, Chu H, Tong N, Zhu H, Wang M, Qiang F, Zhang Z. The association analysis of lncrna hotair genetic variants and gastric cancer risk in a chinese population. Oncotarget. 2015; 6:31255-62. doi: 10.18632/oncotarget.5158.
21. Li L, Dang Q, Xie H, Yang Z, He D, Liang L, Song W, Yeh S, Chang C. Infiltrating mast cells enhance prostate cancer invasion via altering lncrna-hotair/prc2-androgen receptor (ar)-mmp9 signals and increased stem/progenitor cell population. Oncotarget. 2015; 6:14179-14190. doi: 10.18632/oncotarget.3651
22. Sharma S, Mandal P, Sadhukhan T, Roy Chowdhury R, Ranjan Mondal N, Chakravarty B, Chatterjee T, Roy S, Sengupta S. Bridging links between long noncoding rna hotair and hpv oncoprotein e7 in cervical cancer pathogenesis. Sci Rep. 2015; 5:11724.
23. Wang YL, Overstreet AM, Chen MS, Wang J, Zhao HJ, Ho PC, Smith M, Wang SC. Combined inhibition of egfr and c-abl suppresses the growth of triple-negative breast cancer growth through inhibition of hotair. Oncotarget. 2015; 6:11150-11161. doi: 10.18632/oncotarget.3441